Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
AstraZeneca
QuintilesIMS
Cerilliant
Medtronic
Colorcon
Julphar
Farmers Insurance

Generated: September 25, 2018

DrugPatentWatch Database Preview

AKBETA Drug Profile

« Back to Dashboard

When do Akbeta patents expire, and when can generic versions of Akbeta launch?

Akbeta is a drug marketed by Akorn and is included in two NDAs.

The generic ingredient in AKBETA is levobunolol hydrochloride. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.

Summary for AKBETA
US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: 42
Patent Applications: 472
DailyMed Link:AKBETA at DailyMed
Drug patent expirations by year for AKBETA
Medical Subject Heading (MeSH) Categories for AKBETA
Synonyms for AKBETA
(-) -Levobunolol hydrochloride
(-)-3,4-Dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-1(2H)-naphthalenone hydrochloride
(-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone hydrochloride
(-)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalene-1(2H)-one hydrochloride
(-)-Bunolol
(2S)-N-(tert-butyl)-2-hydroxy-3-[(5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]propan-1-aminium chloride
(S)-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone
(S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-3,4-dihydronaphthalen-1(2H)-one
1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride, (-)-
1(2H)-Naphthalenone, 3,4-dihydro-5-(3-(tert-butylamino)-2-hydroxypropoxy)-, hydrochloride,(-)-
1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, (S)-
1(2H)-Naphthalenone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-, hydrochloride, (-)-
27912-14-7
3B1-005467
47141-42-4
5-({(2S)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-3,4-dihydronaphthalen-1(2H)-one hydrochloride
5-[(2S)-3-(tert-butylamino)-2-hydroxy-propoxy]tetralin-1-one hydrochloride
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalen-1-one
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one hydrochloride
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one hydrochloride
5-[(2S)-3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone
5-{[3-(tert-butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one hydrochloride
AC1L21RP
AC1L9B4G
AC1NR4EJ
AC1Q6JRH
ACM27867056
AJ-45756
Ak-beta
AK-Beta (TN)
AK?
AK122598
AKOS016012242
AKOS030526127
AN-15275
API0003156
AX8246776
beta-site
Betagan
Betagan (TN)
Betegan (TN)
BPBio1_000917
BRD-K31812033-003-03-7
BSPBio_000833
C-18293
C07914
C17H25NO3.HCl
CAS-27912-14-7
CAS-47141-41-3
CC-29916
CCG-220847
CCRIS 4375
CHEBI:6438
CHEBI:6439
CHEMBL1201177
CHEMBL1201237
CS-4554
CTK8G0556
D00IUG
D01025
D08115
DB01210
DNTDOBSIBZKFCP-YDALLXLXSA-N
DSSTox_CID_777
DSSTox_GSID_20777
DSSTox_RID_75784
DTXSID1043833
DTXSID6020777
EINECS 248-725-3
ent-Levobunolol, Hydrochloride
ent-Levobunolol,Hydrochloride
FT-0604397
G6317AOI7K
Gotensin
GTPL570
HMS1570J15
HY-B1035
IXHBTMCLRNMKHZ-LBPRGKRZSA-N
KB-211580
l-Bunolol
l-Bunolol hydrochloride
LEVOBUNOLOL
Levobunolol (hydrochloride)
Levobunolol (INN)
Levobunolol [INN:BAN]
Levobunolol HCl
levobunolol hydrochloride
Levobunolol hydrochloride (JAN/USP)
Levobunolol hydrochloride [USAN:USP]
Levobunolol hydrochloride [USAN]
levobunolol monohydrochloride
Levobunolol, Hydrochloride
Levobunolol.HCl
Levobunololum
Levobunololum [INN-Latin]
liquifilm
Liquifilm (TN)
LS-175034
LS-7472
MLS002154030
MolPort-003-848-379
NCGC00016801-01
NCGC00016801-02
NCGC00016801-03
NCGC00016801-05
O90S49LDHH
OR064774
OR272424
Prestwick_167
Prestwick0_000847
Prestwick1_000847
Prestwick2_000847
Prestwick3_000847
SCHEMBL24095
SCHEMBL42262
SMR001233357
SPBio_002754
tert-butyl-[(2S)-2-hydroxy-3-[(5-oxo-7,8-dihydro-6H-naphthalen-1-yl)oxy]propyl]azanium chloride
Tox21_110617
Tox21_110617_1
UNII-71QSY2UT3G component IXHBTMCLRNMKHZ-LBPRGKRZSA-N
UNII-G6317AOI7K
UNII-O90S49LDHH
UNII-W0Q9J8634Z component DNTDOBSIBZKFCP-YDALLXLXSA-N
Vistagan
W 6421A
W 7000A
W-6412A
W-6421A
W-7000A
ZINC3830339

US Patents and Regulatory Information for AKBETA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn AKBETA levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 074779-001 Oct 29, 1996 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn AKBETA levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 074780-001 Oct 29, 1996 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
AstraZeneca
QuintilesIMS
Cerilliant
Medtronic
Colorcon
Julphar
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.